LGALS3BP antibody
Ref. 3D-10R-4627
| 100µl | 1,084.00 € |
Product Information
The LGALS3BP antibody is a highly specialized monoclonal antibody that targets the fatty acid cyclase-activating protein (LGALS3BP). It is designed to specifically bind to LGALS3BP and neutralize its activity. This antibody has been extensively studied in the field of Life Sciences and has shown promising results in various applications.
One of the key characteristics of this antibody is its ability to inhibit low-density lipoprotein (LDL) oxidation, which plays a crucial role in the development of atherosclerosis. By targeting LGALS3BP, this antibody prevents the activation of LDL oxidation pathways, thereby reducing the risk of cardiovascular diseases.
Furthermore, studies have demonstrated that the LGALS3BP antibody can effectively block the binding of ketamine to its receptor, providing potential therapeutic benefits for conditions such as depression and chronic pain management.
In addition to these remarkable properties, this monoclonal antibody has also shown efficacy in neutralizing various viruses by targeting conformational epitopes on their surface
Chemical properties
Technical inquiry about: 3D-10R-4627 LGALS3BP antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
